Resveratrol was esterified with selected fatty acids to improve its lipophilicity and potential application in food and biological systems. In this study, resveratrol and monoesters of resveratryl propionate (RC3:0) and resveratryl docosahexaenate (RDHA) were examined for their effects on anti-inflammatory and anti-proliferative activity in vitro. All test compounds showed a decreased nitrite production in murine RAW 264.7 cells in a concentration dependent manner. Resveratrol, RC3:0, and RDHA were evaluated for their effects on cell viability using liver cancer (HepG2), colon cancer (HT-29, A431), breast cancer (MCF7), and gastric cancer (AGS) cell lines. All test compounds showed decreased cell viability of HepG2, A431, MCF7, HT-29, and AGS in a concentration-dependent manner. The results suggest that resveratrol esters may serve as potential anti-inflammatory and anti-proliferative agents.
Baur, J.A., and Sinclair, D.A. (2006). Therapeutic potential of resveratrol: The in vivo evidence. Nat. Rev. Drug Discov. 5: 493–506.
Bi, X.L., Yang, J.Y., Dong, Y.X., Wang, J.M., Cui, Y.H., Ikeshima, T., Zhao, Y.Q., and Wu, C.F. (2005). Resveratrol inhibits nitric oxide and TNF-α production by lipopolysaccharide-activated microglia. Int. Immunopharmacol. 5: 185–193.
Bove, K., Lincoln, D.W., and Tsan, M. -F. (2002). Effect of resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo. Biochem. Biophys. Res. Commun. 291: 1001–1005.
Cardile, V., Lombardo, L., Spatafora, C., and Tringali, C. (2005). Chemo-enzymatic synthesis and cell-growth inhibition activity of resveratrol analogues. Bioorg. Chem. 33: 22–33.
Cichocki, M., Paluszczak, J., Szaefer, H., Piechowiak, A., Rimando, A.M., and Baer-Dubowska, W. (2008). Pterostilbene is equally potent as resveratrol in inhibiting 12-O-tetradecanoylphorbol-13-acetate activated NFκB, AP-1, COX-2, and iNOS in mouse epidermis. Mol. Nutr. Food Res. 52: 62–70.
Coleman, J.W. (2001). Nitric oxide in immunity and inflammation. Int. Immunopharmacol. 1: 1397–1406.
Dercks, W., and Creasy, L.L. (1989). Influence of fosetyl-A1 on phytoalexin accumulation in the Plasmopara viticola-grapevine interaction. Physiol. Mol. Plant Pathol. 34: 203–213.
Donnelly, L.E., Newton, R., Kennedy, G.E., Fenwick, P.S., Leung, R.H.F., Ito, K., Russell, R.E.K., and Barnes, P.J. (2004). Anti-inflammatory effects of resveratrol in lung epithelial cells: Molecular mechanisms. Am. J. Physiol. Lung Cell Mol. Physiol. 287: 774–783.
Fragopoulou, E., Nomikos, T., Karantonis, H.C., Apostolakis, C., Pliakis, E., Samiotaki, M., Panayotou, G., and Antonopoulou, S. (2007). Biological activity of acetylated phenolic compounds. J. Agric. Food Chem. 55: 80–89.
Fransen, M., Nordgren, M., Wang, B., and Apanasets, O. (2012). Role of peroxisomes in ROS/RNS-metabolism: Implications for human disease. Biochim. Biophys. Acta. 1822: 1363–1373.
Halliwell, B. (1996). Free radicals, proteins and DNA: Oxidative damage versus redox regulation. Biochem. Soc. Trans. 24: 1023–1027.
Jang, M., Cai, L., Udeani, G.O., Slowing, K.V., Thomas, C.F., Beecher, C.W.W., Fong, H.H.S., Farnsworth, N.R., Kinghorn, A.D., Mehta, R.G., Moon, R.C., and Pezzuto, J.M. (1997). Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218–220.
Kruidenier, L., and Verspaget, H.W. (2002). Review article: Oxidative stress as a pathogenic factor in inflammatory bowel disease - radicals or ridiculous? Aliment. Pharmacol. Ther. 16: 1997–2015.
Loft, S., and Poulsen, H.E. (1996). Cancer risk and oxidative DNA damage in man. J. Mol. Med. 74: 297–312.
Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. lmmunol. Methods. 65: 55–63.
Oh, W.Y., and Shahidi, F. (2017). Lipophilization of resveratrol and effects on antioxidant activities. J. Agric. Food Chem. 65: 8617–8625.
Pan, M. -H., Chang, Y. -H., Badmaev, V., Nagabhushanam, K., and Ho, C. -T. (2007). Pterostilbene induces apoptosis and cell cycle arrest in human gastric carcinoma cells. J. Agric. Food Chem. 55: 7777–7785.
Patel, K.R., Brown, V.A., Jones, D.J.L., Britton, R.G., Hemingway, D., Miller, A.S., West, K.P., Booth, T.D., Perloff, M., Crowell, J.A., Brenner, D.E., Steward, W.P., Gescher, A.J., and Brown, K. (2010). Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res. 70: 7392–7399.
Torres, P., Poveda, A., Jimenez-Barbero, J., Ballesteros, A., and Plou, F.J. (2010). Regioselective lipase-catalyzed synthesis of 3-O-acyl derivatives of resveratrol and study of their antioxidant properties. J. Agric. Food Chem. 58: 807–813.
Tsai, S. -H., Lin-Shiau, S. -Y., and Lin, J. -K. (1999). Suppression of nitric oxide synthase and the down-regulation of the activation of NFκB in macrophages by resveratrol. Br. J. Pharmacol. 126: 673–680.
Walle, T., Hsieh, F., Delegge, M.H., Oatis, J.E., and Walle, U.K. (2004). High absortion but very low bioavaibility of oral resveratrol in humans. Drug Metab. Dispos. 32(12): 1377–1382.
Wang, Y., Catana, F., Yang, Y., Roderick, R., and van Breemen, R.B. (2002). An LC-MS method for analyzing total resveratrol in grape juice, cranberry juice, and in wine. J. Agric. Food Chem. 50: 431–435.
Wiseman, H., and Halliwell, B. (1996). Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer. Biochem. J. 313: 17–29.
Yu, B.P. (1994). Cellular defenses against damage from reactive oxygen species. Physiol. Rev. 74: 139–162.
Zhong, M., Cheng, G.F., Wang, W.J., Guo, Y., Zhu, X.Y., and Zhang, J.T. (1999). Inhibitory effect of resveratrol on interleukin 6 release by stimulated peritoneal macrophages of mice. Phytomedicine. 6: 79–84.
Zhong, Y., Chiou, Y. -S., Pan, M. -H., and Shahidi, F. (2012). Anti-inflammatory activity of lipophilic epigallocatechin gallate (EGCG) derivatives in LPS-stimulated murine macrophages. Food Chem. 134: 742–748.
Zhong, Y., and Shahidi, F. (2011). Lipophilized epigallocatechin gallate (EGCG) eerivatives as novel antioxidants. J. Agric. Food Chem. 59: 6526–6533.